Skip to content
← Full study record

NCT01346267 · OUTCOME

Efficacy of Treatment on CIN During Delayed Phase of Chemotherapy

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy · Source last updated 2021-08-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Maximum of 7 days after Acute Phase

What was measured

CIN = Chemotherapy-Induced Nausea. The delayed phase began at the end of the acute phase and continued until the first chemotherapy dose of the next chemotherapy block. Delayed Phase - Bands will continue to be worn for a maximum of 7 days or until the next chemotherapy cycle starts, whichever comes first. Nausea severity is defined as the maximum PeNAT (Pediatric Nausea Assessment Tool) score observed during each 24 hour period. The possible scores for the pediatric nausea assessment tool are no nausea, mild nausea, moderate nausea, severe nausea. Only patients who contributed at least 1 PeNAT score during the delayed phase were included.

Analysis population: The overall number of patients analyzed is 83 for Arm I and 82 for Arm II. Patients analyzed include the total number of patients that reported at least 1 PeNAT (Pediatric Nausea Assessment Tool) score on that day. The duration of the acute phase varied with chemotherapy regimen, according to study design. The number of patients receiving chemotherapy for longer than 3 days diminished each day, so days 4-7 were collapsed and considered a single day.

Groups in this outcome

Arm I- Real Acupressure Bands

Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference. Real Acupressure Band: Acupressure wristband

Arm II- Placebo Acupressure Bands

Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I. Placebo Acupressure Band: Sham wristband

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I- Real Acupressure Bands83
Arm II- Placebo Acupressure Bands82

Reported measurements

Day 1

Analysis denominator · Participants

GroupSource count
Arm I- Real Acupressure Bands75
Arm II- Placebo Acupressure Bands68

No Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands27Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands27Not reportedNot reportedNot reportedNot reported

Mild Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands19Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands15Not reportedNot reportedNot reportedNot reported

Moderate Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands19Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands13Not reportedNot reportedNot reportedNot reported

Severe Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands10Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands13Not reportedNot reportedNot reportedNot reported
Day 2

Analysis denominator · Participants

GroupSource count
Arm I- Real Acupressure Bands67
Arm II- Placebo Acupressure Bands62

No Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands28Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands25Not reportedNot reportedNot reportedNot reported

Mild Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands15Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands20Not reportedNot reportedNot reportedNot reported

Moderate Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands15Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands12Not reportedNot reportedNot reportedNot reported

Severe Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands9Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands5Not reportedNot reportedNot reportedNot reported
Day 3

Analysis denominator · Participants

GroupSource count
Arm I- Real Acupressure Bands65
Arm II- Placebo Acupressure Bands61

No Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands28Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands33Not reportedNot reportedNot reportedNot reported

Mild Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands21Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands14Not reportedNot reportedNot reportedNot reported

Moderate Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands12Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands7Not reportedNot reportedNot reportedNot reported

Severe Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands4Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands7Not reportedNot reportedNot reportedNot reported
Days 4-7

Analysis denominator · Participants

GroupSource count
Arm I- Real Acupressure Bands56
Arm II- Placebo Acupressure Bands51

No Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands19Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands28Not reportedNot reportedNot reportedNot reported

Mild Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands13Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands13Not reportedNot reportedNot reportedNot reported

Moderate Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands14Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands3Not reportedNot reportedNot reportedNot reported

Severe Nausea

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I- Real Acupressure Bands10Not reportedNot reportedNot reportedNot reported
Arm II- Placebo Acupressure Bands7Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        27
      2. group Id
        OG001
        value
        27
      title
      No Nausea
    2. measurements
      1. group Id
        OG000
        value
        19
      2. group Id
        OG001
        value
        15
      title
      Mild Nausea
    3. measurements
      1. group Id
        OG000
        value
        19
      2. group Id
        OG001
        value
        13
      title
      Moderate Nausea
    4. measurements
      1. group Id
        OG000
        value
        10
      2. group Id
        OG001
        value
        13
      title
      Severe Nausea
    denoms
    1. counts
      1. group Id
        OG000
        value
        75
      2. group Id
        OG001
        value
        68
      units
      Participants
    title
    Day 1
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        28
      2. group Id
        OG001
        value
        25
      title
      No Nausea
    2. measurements
      1. group Id
        OG000
        value
        15
      2. group Id
        OG001
        value
        20
      title
      Mild Nausea
    3. measurements
      1. group Id
        OG000
        value
        15
      2. group Id
        OG001
        value
        12
      title
      Moderate Nausea
    4. measurements
      1. group Id
        OG000
        value
        9
      2. group Id
        OG001
        value
        5
      title
      Severe Nausea
    denoms
    1. counts
      1. group Id
        OG000
        value
        67
      2. group Id
        OG001
        value
        62
      units
      Participants
    title
    Day 2
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        28
      2. group Id
        OG001
        value
        33
      title
      No Nausea
    2. measurements
      1. group Id
        OG000
        value
        21
      2. group Id
        OG001
        value
        14
      title
      Mild Nausea
    3. measurements
      1. group Id
        OG000
        value
        12
      2. group Id
        OG001
        value
        7
      title
      Moderate Nausea
    4. measurements
      1. group Id
        OG000
        value
        4
      2. group Id
        OG001
        value
        7
      title
      Severe Nausea
    denoms
    1. counts
      1. group Id
        OG000
        value
        65
      2. group Id
        OG001
        value
        61
      units
      Participants
    title
    Day 3
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        19
      2. group Id
        OG001
        value
        28
      title
      No Nausea
    2. measurements
      1. group Id
        OG000
        value
        13
      2. group Id
        OG001
        value
        13
      title
      Mild Nausea
    3. measurements
      1. group Id
        OG000
        value
        14
      2. group Id
        OG001
        value
        3
      title
      Moderate Nausea
    4. measurements
      1. group Id
        OG000
        value
        10
      2. group Id
        OG001
        value
        7
      title
      Severe Nausea
    denoms
    1. counts
      1. group Id
        OG000
        value
        56
      2. group Id
        OG001
        value
        51
      units
      Participants
    title
    Days 4-7
denoms
  1. counts
    1. group Id
      OG000
      value
      83
    2. group Id
      OG001
      value
      82
    units
    Participants
description
CIN = Chemotherapy-Induced Nausea. The delayed phase began at the end of the acute phase and continued until the first chemotherapy dose of the next chemotherapy block. Delayed Phase - Bands will continue to be worn for a maximum of 7 days or until the next chemotherapy cycle starts, whichever comes first. Nausea severity is defined as the maximum PeNAT (Pediatric Nausea Assessment Tool) score observed during each 24 hour period. The possible scores for the pediatric nausea assessment tool are no nausea, mild nausea, moderate nausea, severe nausea. Only patients who contributed at least 1 PeNAT score during the delayed phase were included.
groups
  1. description
    Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference. Real Acupressure Band: Acupressure wristband
    id
    OG000
    title
    Arm I- Real Acupressure Bands
  2. description
    Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I. Placebo Acupressure Band: Sham wristband
    id
    OG001
    title
    Arm II- Placebo Acupressure Bands
param Type
COUNT_OF_PARTICIPANTS
population Description
The overall number of patients analyzed is 83 for Arm I and 82 for Arm II. Patients analyzed include the total number of patients that reported at least 1 PeNAT (Pediatric Nausea Assessment Tool) score on that day. The duration of the acute phase varied with chemotherapy regimen, according to study design. The number of patients receiving chemotherapy for longer than 3 days diminished each day, so days 4-7 were collapsed and considered a single day.
reporting Status
POSTED
time Frame
Maximum of 7 days after Acute Phase
title
Efficacy of Treatment on CIN During Delayed Phase of Chemotherapy
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice